M&T Bank’s Agios Pharmaceuticals AGIO Stock Holding History

M&T Bank’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-300	Closed	-$10.6M	–	1592
2020 Q1	$10.6M	Buy	+300	New	+$13.9K	0.06%	229
2019 Q2	–	Sell	-3,291	Closed	-$221K	–	1610
2019 Q1	$221K	Buy	+3,291	New	+$192K	﹤0.01%	1367
2018 Q4	–	Sell	-3,706	Closed	-$285K	–	1431
2018 Q3	$285K	Sell	3,706 -31	-0.8%	-$2.49K	﹤0.01%	1258
2018 Q2	$315K	Buy	3,737 +167	+5%	+$14.6K	﹤0.01%	1202
2018 Q1	$293K	Buy	+3,570	New	+$276K	﹤0.01%	1225
2016 Q2	–	Sell	-6,793	Closed	-$277K	–	1695
2016 Q1	$277K	Sell	6,793 -25	-0.4%	-$1.07K	﹤0.01%	1316
2015 Q4	$442K	Sell	6,818 -1,015	-13%	-$66.6K	﹤0.01%	1117
2015 Q3	$554K	Buy	7,833 +2,454	+46%	+$240K	﹤0.01%	1026
2015 Q2	$597K	Sell	5,379 -1,320	-20%	-$142K	﹤0.01%	1118
2015 Q1	$633K	Buy	6,699 +949	+17%	+$106K	﹤0.01%	1068
2014 Q4	$643K	Buy	5,750 +620	+12%	+$55.4K	﹤0.01%	1077
2014 Q3	$315K	Buy	+5,130	New	+$221K	﹤0.01%	1528

Other funds holding AGIO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

M&T Bank's AGIO Position: Q2 2020 in Review

M&T Bank sold out of Agios Pharmaceuticals (AGIO) in Q2 2020, closing a stake of 300 shares — an estimated $10.6M sold.

M&T Bank first reported a position in AGIO in Q3 2014 and held it in 12 quarters. The position peaked at $10.6M in Q1 2020. 216 funds tracked by Wall St. Rank hold AGIO as of Q2 2020.

M&T Bank reported no remaining Agios Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
M&T Bank sold 300 Agios Pharmaceuticals shares in Q2 2020, an estimated $10.6M.
M&T Bank first reported a position in Agios Pharmaceuticals in Q3 2014 and held it in 12 quarters.
M&T Bank's Agios Pharmaceuticals position peaked at $10.6M in Q1 2020.
216 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2020.

Based on M&T Bank's 13F filing for Q2 2020, filed 29 Jul 2020.